about
Positron emission tomography-adapted therapy for first-line treatment in individuals with Hodgkin lymphomaPositron emission tomography (PET)-adapted therapy for Hodgkin lymphoma patientsOccurrence of minimal change nephrotic syndrome in classical Hodgkin lymphoma is closely related to the induction of c-mip in Hodgkin-Reed Sternberg cells and podocytesReticuloendothelial malignancy of head and neck: A comprehensive reviewApplication of MALDI imaging for the diagnosis of classical Hodgkin lymphoma.Rare expression of T-cell markers in classical Hodgkin's lymphoma.Hodgkin lymphoma at the paediatric oncology unit of gabriel touré teaching hospital, bamako, mali: 5-year experienceEpstein-Barr virus-associated lymphomas.Diffuse large B-cell lymphoma: one or more entities? Present controversies and possible tools for its subclassification.The molecular basis for the generation of Hodgkin and Reed-Sternberg cells in Hodgkin's lymphoma.Somatic hypermutation patterns in germinal center B cell malignancies.CD30 Downregulation, MMAE Resistance, and MDR1 Upregulation Are All Associated with Resistance to Brentuximab Vedotin.Hodgkin's lymphoma (relapsed or refractory): autologous stem cell therapy.Immunohistochemical and molecular detection of the expression of FGF23 in phosphaturic mesenchymal tumors including the non-phosphaturic variant.Recent insights into the biology of Hodgkin lymphoma: unraveling the mysteries of the Reed-Sternberg cell.Prognostic significance of pretreatment serum cytokines in classical Hodgkin lymphoma.Is There an Association Between Synovial CD30+ T Lymphocyte Count and Chondral Lesion Depth?Differences in outcome of patients with syncytial variant Hodgkin lymphoma compared with typical nodular sclerosis Hodgkin lymphoma.Differential diagnosis of classic Hodgkin lymphoma.Multiple primary enoral soft tissue manifestations of a Hodgkin lymphoma--case report and literature review.Lymphocyte Rich Hodgkin's Lymphoma Presented with Warm Hemolytic Anemia: A Case Report and Literature Review.Nivolumab for the treatment of classical Hodgkin lymphoma after failure of autologous stem cell transplant and brentuximab.Mechanisms underlying the association between obesity and Hodgkin lymphoma.Targeting the IL-4/IL-13 signaling pathway sensitizes Hodgkin lymphoma cells to chemotherapeutic drugs.Management of Hodgkins Lymphoma: ICMR Consensus Document.Non-Coding RNAs in Hodgkin Lymphoma.Hodgkin lymphoma mimicking a large soft tissue sarcoma of the shoulder: the essential role of immunohistochemistry in histopathological diagnosis.Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin's Lymphoma.Mediastinal Gray Zone Lymphoma: A Wider Category Than We Think?Epstein-Barr virus infection is inversely correlated with the expression of retinoblastoma protein in Reed-Sternberg cells in classic Hodgkin lymphoma.A Diagnostic Surprise: Primary Hodgkin's Lymphoma of the Lung.Multiplexed detection and characterization of rare tumor cells in Hodgkin's lymphoma with multicolor quantum dots.How do we define Hodgkin's disease? The authors' reply.BEACOPP escalated and rituximab in the treatment of Hodgkin lymphoma occurring concurrently with diffuse large B-cell non-Hodgkin lymphoma.Pediatric Hodgkin Lymphoma Treated at Cancer Institute, Chennai, India: Long-Term Outcome.Epstein-Barr virus expression in Hodgkin's lymphoma in Kuwait.Grand Round Presentation.Lymphocyte depleted Hodgkin lymphoma: an evaluation with immunophenotyping and genetic analysis.Unproven value of end-of-treatment FDG-PET in Hodgkin lymphoma.Interim FDG-PET in lymphoma, a questionable practice in hematology.
P2860
Q24186668-FE403793-6A30-4BD4-9BE4-4646CB3A5503Q24202622-6D06211F-74EC-4C08-BC3B-E2CF5A6D28E2Q24630620-BCC16C63-0860-419D-97F2-058EB332145BQ28084523-6C6A5710-0E27-41FE-8684-13AB350F783FQ33701896-C2667508-A306-4205-A889-5B333440C5CBQ34438875-695D7C96-511A-47F7-8578-280495237208Q34590943-5D93202F-87AC-4DFF-925A-AD55D8C2351FQ34651670-EF83DB4A-8DCC-48B7-8BE7-62C3F1E48677Q35013338-787EBED7-6BC8-4F5C-BE4B-9F6B1FBCD612Q35140197-B029BDCF-0C44-495E-9EAB-9201F5B1211AQ35552528-F0C0BE2C-116C-4A98-96D2-42ADA0372CD0Q35691210-E180F847-7C28-413A-885B-46D72CC80A74Q35821412-BAAA40AF-F1C1-4673-A3C2-B28D14B78D80Q36668178-DA2DE3BF-AE52-4170-B3BD-51183A2F02BFQ37004635-BA9B0D83-2B3A-45B9-9AA2-BCC95F595812Q37402310-70E6FB8E-E85C-4CC7-B314-885180E7B711Q37502094-018D7823-80B4-4A1C-B49E-60732DF9EFA2Q37514622-5BF7F76A-0769-47EC-9469-3139E84A9326Q37756387-FDD9B6BC-AB34-4BA5-97E8-B5DB9EECBCA7Q38004918-0317900F-54C2-4968-AEDD-3479FA1653ABQ38039425-45246B85-CB74-49D2-9E9E-847F6235B500Q38636284-48F1CD30-F2B2-47A9-B422-517C9EA55A51Q38910560-5A836F74-392E-4D90-831B-D0933761562AQ39171993-162C2EFF-C468-429D-BCC2-9CFCE99B77F0Q39208309-1631D9DD-6B06-47E4-AF8B-E2CFEDDCC06CQ39336949-AA2F00F9-ACC3-4466-840D-688A7A16B124Q39929771-54CC1C39-863F-4DA8-9585-E62CF6E8A317Q40042049-2B8876D5-08E9-4563-A874-3DBBC1157510Q40864458-F73FBCB9-341A-4186-A0ED-0A9DA65C3CA3Q41570251-F61F3A6C-AE02-48EC-9678-AF1A4736480BQ42375590-4F496F78-9664-4099-B837-9A75187A5CB3Q42592557-5B21F472-08BF-41C0-AE89-645E81B5998EQ43011229-BAFB0C11-8C97-4F68-A8C8-9662AACD70A9Q44027413-473BFFE3-37CC-45CD-AD74-8A65DFE5EF34Q44065723-2C719039-0DC5-4E3D-BC3D-34780508F6DCQ45710905-EF5A3590-F3C9-4143-BD5A-EB09A2927B00Q45753191-896E299D-D1C4-48BD-BAEB-7F8F582116E8Q47763298-1D4FA9C9-F3F7-4678-8693-8EAE7B302CA7Q48127652-64C39A5F-AB85-4474-BCE4-812B4744CA50Q48316502-4E436A75-5F60-43E5-865C-36B8327B6A8C
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Hodgkin's lymphoma: the pathologist's viewpoint
@ast
Hodgkin's lymphoma: the pathologist's viewpoint
@en
Hodgkin's lymphoma: the pathologist's viewpoint
@nl
type
label
Hodgkin's lymphoma: the pathologist's viewpoint
@ast
Hodgkin's lymphoma: the pathologist's viewpoint
@en
Hodgkin's lymphoma: the pathologist's viewpoint
@nl
prefLabel
Hodgkin's lymphoma: the pathologist's viewpoint
@ast
Hodgkin's lymphoma: the pathologist's viewpoint
@en
Hodgkin's lymphoma: the pathologist's viewpoint
@nl
P2093
P2860
P356
P1476
Hodgkin's lymphoma: the pathologist's viewpoint
@en
P2093
E Sabattini
P L Zinzani
P P Piccaluga
S A Pileri
P2860
P304
P356
10.1136/JCP.55.3.162
P407
P577
2002-03-01T00:00:00Z